Prospective Evaluation to Establish a Dose Response for Clinical Oral Mucositis in Patients Undergoing Head-and-Neck Conformal Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 3, 2008, Pages

  Narayan, Samir ^a   Lehmann, Joerg ^a   Coleman, Matthew A ^b   Vaughan, Andrew ^a   Yang, Claus Chunli ^a   Enepekides, Danny ^a   Farwell, Gregory ^a   Purdy, James A ^a   Laredo, Grace ^a   Nolan, Kerry ^b   Pearson, Francesca S ^b   Vijayakumar, Srinivasan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Buccal mucosa; Head and neck cancer; Mucositis; Radiation therapy; RNA analysis

Indexed keywords

CHAINS; DISEASES; POLYMERASE CHAIN REACTION; RNA; STATIC RANDOM ACCESS STORAGE;

BUCCAL MUCOSA; CONFORMAL RADIOTHERAPY; HEAD-AND-NECK CANCER; MUCOSITIS; NATIONAL CANCER INSTITUTE; PROSPECTIVE EVALUATION; RNA ANALYSIS; TREATMENT PLANNING SYSTEMS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CHEEK; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DOSIMETRY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; MUCOSA INFLAMMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RNA ANALYSIS; TREATMENT PLANNING; TREATMENT RESPONSE;

EID: 52949128752     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.01.060     Document Type: Article

References (33)

1. Sonis S.T. The pathobiology of mucositis. Nat Rev 4 (2004) 277-284
2. Elting L.S., Cooksley C.D., Chambers M.S., et al. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68 (2007) 1110-1120
3. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
4. Sonis S.T., Elting L.S., Keefe D., et al. Mucositis study section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 (2004) 1995-2025
5. Sanguineti G., Sosa M., Culp L., et al. Is it feasible to spare part of the mucosa with IMRT and does it matter. Int J Radiat Oncol Biol Phys 60 Suppl. (2004) S517-S518
6. Marcie S., Charpiot E., Bensadoun R., et al. In vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 61 (2005) 1603-1606
7. Amundson S.A., Do K.T., Fornace Jr. A.J., et al. Induction of stress genes by low doses of gamma rays. Radiat Res 152 (1999) 225-231
8. Amundson S.A., Lee R.A., Koch-Paiz C.A., et al. Differential responses of stress genes to low dose-rate gamma irradiation. Mol Cancer Res 1 (2003) 445-452
9. Spivack S.D., Hurteau G.J., Jain R., et al. Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res 64 (2004) 6805-6813
10. Parsons J.T. The effect of radiation on normal tissues of the head and neck. In: Million R.R., and Cassisi N.J. (Eds). Management of head and neck cancer: A multidisciplinary approach. 2nd Ed. (1994), Lippincott, Philadelphia, PA 245-289
11. Vera-Llonch M., Oster G., Hagiwara M., et al. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106 (2006) 329-336
12. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys 51 (2001) 880-914
13. Sanguineti G., Endres E.J., Gunn B.G., et al. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?. Int J Radiat Oncol Biol Phys 66 (2006) 931-938
14. Amdur R.J., Li J.G., Liu C., et al. Unnecessary laryngeal irradiation in the IMRT era. Head Neck 26 (2004) 257-263
15. Dornfeld K., Simmons J.R., Karnell L., et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int J Radiat Oncol Biol Phys 68 (2007) 750-755
16. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 66 (2003) 253-262
17. Denham J.W., Hamilton C.S., Christie T.D., et al. Acute reaction parameters for human oropharyngeal mucosa. Radiother Oncol 35 (1995) 129-137
18. Rezvan M., Alcock C.J., Fowler J.F., et al. Normal tissue reactions in the British Institute of Radiology. Study of 3 fractions per week versus 5 fractions per week in the treatment of carcinoma of the laryngo-pharynx by radiotherapy. Br J Radiol 64 (1991) 1122-1133
19. Kutcher G.J., and Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 16 (1989) 1623-1630
20. Lyman J.T., and Wolbarst A.B. Optimization of radiation therapy III: A method of assessing complication probabilities from dose volume histograms. Int J Radiat Oncol Biol Phys 13 (1987) 103-109
21. Milano M.T., Constine L.S., and Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 17 (2007) 131-140
22. Vargas C., Martinez A., Kestin L.L., et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1297-1308
23. Maguire P.D., Sibley G.S., Zhou S.M., et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 44 (1999) 97-103
24. Denis F., Garaud P., Bardet E., et al. Late toxicity results of the GEORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced stage oropharynx carcinoma: Comparison of the LENT/SOMA, RTOG/EORTC and NCI-CTC: scoring systems. Int J Radiat Oncol Biol Phys 55 (2003) 93-98
25. Scully C., Sonis S., and Diz P.H. Oral mucositis. Oral Dis 12 (2006) 229-241
26. Stokman M.A., Spijkervet F.K., Boezen H.M., et al. Prevention of oral mucositis in cancer patients treated with chemotherapy or radiotherapy. Evid Based Dent 7 (2006) 81-82
27. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
28. Bentzen S., Saunders M., Dische S., et al. Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60 (2001) 123-135
29. Fowler J.F., Harari P.M., Leborgne F., et al. Acute radiation reactions in oral and pharyngeal mucosa: Tolerable levels in altered fractionation schedules. Radiother Oncol 69 (2003) 161-168
30. Kaanders J.H.A.M., van der Kogel A.J., and Ann K.K. Altered fractionation: Limited by mucosal reactions?. Radiother Oncol 50 (1999) 247-260
31. Shogan G., Bhatnagar A., Heron D., et al. Dosimetric correlation of oral cavity dose with acute mucositis in patients treated with intensity modulated radiation therapy (IMRT) and chemotherapy. [abstract]. Int J Radiat Oncol Biol Phys 63 Suppl. (2005) S73-S74
32. Nygaard V., and Hovig E. Options available for profiling small samples: A review of sample amplification technology when combined with microarray profiling. Nucleic Acid Res 34 (2006) 996-1014
33. Livak K.J., and Schmittingen T.D. Analysis of relative gene expression data using time quantitative PCR and the 2-delta delta CT method. Methods 25 (2001) 402-408